Critical Pharmaceuticals
HomeCompany ProfileNewsTechnologyManagement TeamPipelineEventsContact Us

Latest News
6th September 2011
  Interim Results of CP024 Nasal hGH Phase 1 Program Show Comparable Bioactivity to Injection
5th April 2011
  PolyTherics and Critical Pharmaceuticals enter drug development collaboration with TSB funding
8th March 2011
  CriticalSorb Delivery Technology Shows Excellent Local Tolerability in Long Term Preclinical Studies
Technology
 

Technology

Critical Pharmaceuticals has developed two unique drug delivery technologies:

CriticalSorb for the non-invasive nasal delivery delivery of high-value biologic products and challenging small molecule drugs.

CriticalMix for the manufacture of highly active sustained release depot products for bimonthly, monthly or even less frequent injection.

 
Contact Us

Critical Pharmaceuticals Limited

BioCity Nottingham
Pennyfoot Street
Nottingham
NG1 1GF
United Kingdom

Phone:  +44 (0)115 882 0100
Fax:       +44 (0)115 958 1565
E-mail:   info@criticalpharmaceuticals.com

 

Business Development

Gareth King, PhD
Acting Chief Executive Officer
gareth.king@criticalpharmaceuticals.com
 

Andrew Lewis, MRPharmS PhD
Director Operations
andy.lewis@criticalpharmaceuticals.com

 

join our mailing list
* indicates required field

 
See Our Process
See Videos
Contact Us
Critical Pharmaceuticals
Limited
BioCity Nottingham
Pennyfoot Street
Nottingham
NG1 1GF
United Kingdom
E-mail:
info@criticalpharmaceuticals.com
Home | Company profile | News | Technology | Management team | Pipeline | Events | Contact Us
Copyright 2008 Critical pharmaceuticals. All rights reserved. Website Design by Web creation UK